Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $494,406 - $745,008
-2,200 Reduced 37.93%
3,600 $923,000
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $1.61 Million - $2.12 Million
5,800 New
5,800 $1.91 Million
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $2.62 Million - $3.23 Million
-8,700 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $2.7 Million - $3.27 Million
8,700 New
8,700 $2.87 Million
Q2 2021

Aug 06, 2021

SELL
$262.71 - $351.17 $2.86 Million - $3.83 Million
-10,900 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $8.26 Million - $10.3 Million
-28,900 Reduced 72.61%
10,900 $3.38 Million
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $604,512 - $778,080
-2,400 Reduced 5.69%
39,800 $12.9 Million
Q3 2020

Nov 13, 2020

SELL
$255.22 - $317.0 $918,792 - $1.14 Million
-3,600 Reduced 7.86%
42,200 $11.5 Million
Q2 2020

Aug 13, 2020

SELL
$141.4 - $257.09 $862,540 - $1.57 Million
-6,100 Reduced 11.75%
45,800 $11 Million
Q1 2020

May 11, 2020

SELL
$130.51 - $196.01 $3.24 Million - $4.86 Million
-24,800 Reduced 32.33%
51,900 $7.73 Million
Q4 2019

Feb 12, 2020

BUY
$159.31 - $223.54 $1.75 Million - $2.46 Million
11,000 Added 16.74%
76,700 $12.8 Million
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $510,080 - $809,767
-2,900 Reduced 4.23%
65,700 $11.6 Million
Q2 2019

Aug 20, 2019

BUY
$250.96 - $284.94 $3.59 Million - $4.07 Million
14,300 Added 26.34%
68,600 $17.9 Million
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $3.15 Million - $4.13 Million
11,400 Added 26.57%
54,300 $15.5 Million
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $112,432 - $177,700
-400 Reduced 0.92%
42,900 $13.6 Million
Q3 2018

Nov 14, 2018

BUY
$354.53 - $449.75 $9.08 Million - $11.5 Million
25,600 Added 144.63%
43,300 $19.5 Million
Q1 2018

May 15, 2018

BUY
$192.49 - $295.85 $3.41 Million - $5.24 Million
17,700 New
17,700 $5.15 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.